Adel Y, Alexander SP (2021) Neuromolecular mechanisms of cannabis action. Cannabinoids Neuropsychiatric Disorders 15–28. https://doi.org/10.1007/978-3-030-57369-0_2

Anthony AT, Rahmat S, Sangle P, Sandhu O, Khan S (2020) Cannabinoid receptors and their relationship with chronic pain: a narrative review. Cureus 12(9). https://doi.org/10.7759/cureus.10436

Ashton JC, Glass M (2007) The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration. Curr Neuropharmacol 5(2):73–80. https://doi.org/10.2174/157015907780866884

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aso E, Andrés-Benito P, Ferrer I (2016) Delineating the efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a murine model. J Alzheimers Dis 54(3):903–912. https://doi.org/10.3233/JAD-160533

Article  CAS  PubMed  Google Scholar 

Atwood BK, Mackie K (2010) CB2: a cannabinoid receptor with an identity crisis. Br J Pharmacol 160(3):467–479. https://doi.org/10.1111/j.1476-5381.2010.00729.x

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aychman MM, Goldman DL, Kaplan JS (2023) Cannabidiol’s neuroprotective properties and potential treatment of traumatic brain injuries. Front Neurol 14:1087011. https://doi.org/10.3389/fneur.2023.1087011

Article  PubMed  PubMed Central  Google Scholar 

Bachmeier C, Beaulieu-Abdelahad D, Mullan M, Paris D (2013) Role of the cannabinoid system in the transit of beta-amyloid across the blood–brain barrier. Mol Cell Neurosci 56:255–262. https://doi.org/10.1016/j.mcn.2013.06.004

Article  CAS  PubMed  Google Scholar 

Basu S, Dittel BN (2011) Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease. Immunol Res 51(1):26–38. https://doi.org/10.1007/s12026-011-8210-5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bayewitch M, Avidor-Reiss T, Levy R, Barg J, Mechoulam R, Vogel Z (1995) The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling. FEBS Lett 375(1–2):143–147. https://doi.org/10.1016/0014-5793(95)01207-u

Article  CAS  PubMed  Google Scholar 

Benito C, Tolón RM, Pazos MR, Núñez E, Castillo AI, Romero J (2008) Cannabinoid CB2 receptors in human brain inflammation. Br J Pharmacol 153(2):277–285. https://doi.org/10.1038/sj.bjp.0707505

Article  CAS  PubMed  Google Scholar 

Bie B, Wu J, Foss JF, Naguib M (2018) An overview of the cannabinoid type 2 receptor system and its therapeutic potential. Curr Opin Anaesthesiol 31(4):407–414. https://doi.org/10.1097/ACO.0000000000000616

Article  CAS  PubMed  PubMed Central  Google Scholar 

Block ML, Hong JS (2005) Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 76(2):77–98. https://doi.org/10.1016/j.pneurobio.2005.06.004

Article  CAS  PubMed  Google Scholar 

Bouaboula M, Poinot-Chazel C, Marchand J, Canat X, Bourrié B, Rinaldi-Carmona M, Calandra B, Le Fur G, Casellas P (1996) Signalling pathway associated with stimulation of CB2 peripheral cannabinoid receptor. Involvement of both mitogen-activated protein kinase and induction of Krox-24 expression. Eur J Biochem 237(3):704–711. https://doi.org/10.1111/j.1432-1033.1996.0704p.x

Article  CAS  PubMed  Google Scholar 

Bouchard J, Truong J, Bouchard K, Dunkelberger D, Desrayaud S, Moussaoui S, Tabrizi SJ, Stella N, Muchowski PJ (2012) Cannabinoid receptor 2 signalling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington’s disease. J Neurosci 32(50):18259–18268. https://doi.org/10.1523/JNEUROSCI.4008-12.2012

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bow EW, Rimoldi JM (2016) The structure-function relationships of classical cannabinoids: CB1/CB2 modulation. Perspect Medicin Chem 8:17–39. https://doi.org/10.4137/PMC.S32171

Article  PubMed  PubMed Central  Google Scholar 

Buckley NE, McCoy KL, Mezey E, Bonner T, Zimmer A, Felder CC, Glass M, Zimmer A (2000) Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor. Eur J Pharmacol 396(2–3):141–149. https://doi.org/10.1016/s0014-2999(00)00211-9

Article  CAS  PubMed  Google Scholar 

Bueb JL, Lambert DM, Tschirhart EJ (2001) Receptor-independent effects of natural cannabinoids in rat peritoneal mast cells in vitro. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 1538(2–3):252–259. https://doi.org/10.1016/S0167-4889(01)00076-3

Cabral GA, Griffin-Thomas L (2009) Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation. Expert Rev Mol Med. 2009;11: e3. https://doi.org/10.1017/S1462399409000957

Cabral GA, Toney DM, Fischer-Stenger K, Harrison MP, Marciano-Cabral F (1995) Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cells. Life Sci 56(23–24):2065–2072. https://doi.org/10.1016/0024-3205(95)00190-H

Article  CAS  PubMed  Google Scholar 

Calandra B, Portier M, Kernéis A, Delpech M, Carillon C, Le Fur G, Ferrara P, Shire D (1999) Dual intracellular signalling pathways mediated by the human cannabinoid CB1 receptor. Eur J Pharmacol 374(3):445–455. https://doi.org/10.1016/s0014-2999(99)00349-0

Article  CAS  PubMed  Google Scholar 

Calderon TM, Eugenin EA, Lopez L, Kumar SS, Hesselgesser J, Raine CS, Berman JW (2006) A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein. J Neuroimmunol 177(1–2):27–39. https://doi.org/10.1016/j.jneuroim.2006.05.003

Article  CAS  PubMed  Google Scholar 

Carayon P, Marchand J, Dussossoy D, Derocq JM, Jbilo O, Bord A, Bouaboula M, Galiègue S, Mondiere P, Pénarier G, Fur GL (1998) Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation. Blood J Am Soc Hematol 92(10):3605–3615. https://doi.org/10.1182/blood.V92.10.3605.422k05_3605_3615

Article  CAS  Google Scholar 

Cargnello M, Roux PP (2011) Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases. Microbiol Mol Biol Rev 75(1):50–83. https://doi.org/10.1128/MMBR.00031-10

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen M, Wolynes PG (2017) Aggregation landscapes of huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington’s disease. Proc Natl Acad Sci U S A 114(17):4406–4411. https://doi.org/10.1073/pnas.1702237114

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheung KAK, Peiris H, Wallace G, Holland OJ, Mitchell MD (2019) The interplay between the Endocannabinoid System, Epilepsy and cannabinoids. Int J Mol Sci 20(23):6079. https://doi.org/10.3390/ijms20236079

Article  CAS  PubMed  Google Scholar 

Concannon RM, Dowd E (2016) Central CB2 receptors in inflammation-driven neurodegeneration: dysregulation and therapeutic potential. Neural Regeneration Res 11(9):1409–1410. https://doi.org/10.4103/1673-5374.191208

Article  CAS  Google Scholar 

Condello C, Yuan P, Schain A, Grutzendler J (2015) Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques. Nat Commun 6(1):6176. https://doi.org/10.1038/ncomms7176

Article  CAS  PubMed  Google Scholar 

Correa F, Docagne F, Mestre L, Clemente D, Hernangómez M, Loría F, Guaza CA (2009) Role for CB2 receptors in anandamide signalling pathways involved in the regulation of IL-12 and IL-23 in microglial cells. Biochem Pharmacol 77(1):86–100. https://doi.org/10.1016/j.bcp.2008.09.014

Article  CAS  PubMed  Google Scholar 

Correa F, Hernangómez M, Mestre L, Loría F, Spagnolo A, Docagne F, Di Marzo V, Guaza C (2010) Anandamide enhances IL-10 production in activated microglia by targeting CB(2) receptors: roles of ERK1/2, JNK, and NF-kappaB. Glia 58(2):135–147. https://doi.org/10.1002/glia.20907

Article  PubMed  Google Scholar 

Dalle S, Schouten M, M